94 related articles for article (PubMed ID: 3527502)
1. Class II MHC antigen expression in the atherosclerotic plaque: smooth muscle cells express HLA-DR, HLA-DQ and the invariant gamma chain.
Hansson GK; Jonasson L; Holm J; Claesson-Welsh L
Clin Exp Immunol; 1986 May; 64(2):261-8. PubMed ID: 3527502
[TBL] [Abstract][Full Text] [Related]
2. Vectorial function of major histocompatibility complex class II in a human intestinal cell line.
Lopes LM; Hughson E; Anstee Q; O'Neil D; Katz DR; Chain BM
Immunology; 1999 Sep; 98(1):16-26. PubMed ID: 10469229
[TBL] [Abstract][Full Text] [Related]
3. Human Coronary Plaque T Cells Are Clonal and Cross-React to Virus and Self.
Chowdhury RR; D'Addabbo J; Huang X; Veizades S; Sasagawa K; Louis DM; Cheng P; Sokol J; Jensen A; Tso A; Shankar V; Wendel BS; Bakerman I; Liang G; Koyano T; Fong R; Nau AN; Ahmad H; Gopakumar J; Wirka R; Lee AS; Boyd J; Woo YJ; Quertermous T; Gulati GS; Jaiswal S; Chien YH; Chan CKF; Davis MM; Nguyen PK
Circ Res; 2022 May; 130(10):1510-1530. PubMed ID: 35430876
[TBL] [Abstract][Full Text] [Related]
4. HLA DQ protein changes the cell surface distribution pattern of HLA proteins as monitored by Förster resonance energy transfer and high-resolution electron microscopy.
Kormos J; Veres AJ; Imre L; Mátyus L; Benkő S; Szöllősi J; Jenei A
Cytometry A; 2023 Dec; 103(12):978-991. PubMed ID: 37605541
[TBL] [Abstract][Full Text] [Related]
5. Does epigenetic markers of HLA gene show association with coronary artery disease in Indian subjects?
Banerjee S; Paradkar MU; Ponde CK; Rajani RM; Pillai S; Ashavaid TF
Mol Biol Rep; 2024 Jan; 51(1):173. PubMed ID: 38252175
[TBL] [Abstract][Full Text] [Related]
6. Hypotheses on Atherogenesis Triggering: Does the Infectious Nature of Atherosclerosis Development Have a Substruction?
Lusta KA; Poznyak AV; Sukhorukov VN; Eremin II; Nadelyaeva II; Orekhov AN
Cells; 2023 Feb; 12(5):. PubMed ID: 36899843
[TBL] [Abstract][Full Text] [Related]
7. Single-nucleus chromatin accessibility profiling highlights regulatory mechanisms of coronary artery disease risk.
Turner AW; Hu SS; Mosquera JV; Ma WF; Hodonsky CJ; Wong D; Auguste G; Song Y; Sol-Church K; Farber E; Kundu S; Kundaje A; Lopez NG; Ma L; Ghosh SKB; Onengut-Gumuscu S; Ashley EA; Quertermous T; Finn AV; Leeper NJ; Kovacic JC; Björkegren JLM; Zang C; Miller CL
Nat Genet; 2022 Jun; 54(6):804-816. PubMed ID: 35590109
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed?
Engelen SE; Robinson AJB; Zurke YX; Monaco C
Nat Rev Cardiol; 2022 Aug; 19(8):522-542. PubMed ID: 35102320
[TBL] [Abstract][Full Text] [Related]
9. A heparin-rosuvastatin-loaded P(LLA-CL) nanofiber-covered stent inhibits inflammatory smooth-muscle cell viability to reduce in-stent stenosis and thrombosis.
Liu Y; Liu P; Song Y; Li S; Shi Y; Quan K; Yu G; Li P; An Q; Zhu W
J Nanobiotechnology; 2021 Apr; 19(1):123. PubMed ID: 33926468
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory Cytokines and Atherosclerotic Plaque Progression. Therapeutic Implications.
Sterpetti AV
Curr Atheroscler Rep; 2020 Oct; 22(12):75. PubMed ID: 33025148
[TBL] [Abstract][Full Text] [Related]
11. Stem Cell Pluripotency Genes Klf4 and Oct4 Regulate Complex SMC Phenotypic Changes Critical in Late-Stage Atherosclerotic Lesion Pathogenesis.
Alencar GF; Owsiany KM; Karnewar S; Sukhavasi K; Mocci G; Nguyen AT; Williams CM; Shamsuzzaman S; Mokry M; Henderson CA; Haskins R; Baylis RA; Finn AV; McNamara CA; Zunder ER; Venkata V; Pasterkamp G; Björkegren J; Bekiranov S; Owens GK
Circulation; 2020 Nov; 142(21):2045-2059. PubMed ID: 32674599
[TBL] [Abstract][Full Text] [Related]
12. Inflammation, Immunity, and Infection in Atherothrombosis: JACC Review Topic of the Week.
Libby P; Loscalzo J; Ridker PM; Farkouh ME; Hsue PY; Fuster V; Hasan AA; Amar S
J Am Coll Cardiol; 2018 Oct; 72(17):2071-2081. PubMed ID: 30336831
[TBL] [Abstract][Full Text] [Related]
13. Atherosclerosis as autoimmune disease.
Sima P; Vannucci L; Vetvicka V
Ann Transl Med; 2018 Apr; 6(7):116. PubMed ID: 29955576
[TBL] [Abstract][Full Text] [Related]
14. Atheroma Susceptible to Thrombosis Exhibit Impaired Endothelial Permeability In Vivo as Assessed by Nanoparticle-Based Fluorescence Molecular Imaging.
Stein-Merlob AF; Hara T; McCarthy JR; Mauskapf A; Hamilton JA; Ntziachristos V; Libby P; Jaffer FA
Circ Cardiovasc Imaging; 2017 May; 10(5):. PubMed ID: 28487316
[TBL] [Abstract][Full Text] [Related]
15. Interferon-γ Released by Activated CD8
Nagy E; Lei Y; Martínez-Martínez E; Body SC; Schlotter F; Creager M; Assmann A; Khabbaz K; Libby P; Hansson GK; Aikawa E
Am J Pathol; 2017 Jun; 187(6):1413-1425. PubMed ID: 28431214
[TBL] [Abstract][Full Text] [Related]
16. Beyond vascular inflammation--recent advances in understanding atherosclerosis.
Wolf D; Zirlik A; Ley K
Cell Mol Life Sci; 2015 Oct; 72(20):3853-69. PubMed ID: 26100516
[TBL] [Abstract][Full Text] [Related]
17. Murine aortic smooth muscle cells acquire, though fail to present exogenous protein antigens on major histocompatibility complex class II molecules.
Maddaluno M; MacRitchie N; Grassia G; Ialenti A; Butcher JP; Garside P; Brewer JM; Maffia P
Biomed Res Int; 2014; 2014():949845. PubMed ID: 25136640
[TBL] [Abstract][Full Text] [Related]
18. T helper cell polarization in healthy people: implications for cardiovascular disease.
Olson NC; Sallam R; Doyle MF; Tracy RP; Huber SA
J Cardiovasc Transl Res; 2013 Oct; 6(5):772-86. PubMed ID: 23921946
[TBL] [Abstract][Full Text] [Related]
19. Inflammation and immune system interactions in atherosclerosis.
Legein B; Temmerman L; Biessen EA; Lutgens E
Cell Mol Life Sci; 2013 Oct; 70(20):3847-69. PubMed ID: 23430000
[TBL] [Abstract][Full Text] [Related]
20. Linking immunity to atherosclerosis: implications for vascular pharmacology--a tribute to Göran K. Hansson.
Geng YJ; Jonasson L
Vascul Pharmacol; 2012; 56(1-2):29-33. PubMed ID: 22120836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
